Desh Rakshak Aushdhalaya Ltd

Desh Rakshak Aushdhalaya Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.86% today and exhibiting a complete absence of buyers. This extreme selling activity signals distress among investors, as the stock continues to underperform both its sector and the broader market benchmarks.

Desh Rakshak Aushdhalaya Ltd has attracted extraordinary buying interest, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals a potential multi-day circuit scenario, reflecting intense demand amid a backdrop of mixed performance metrics over various time frames.

Desh Rakshak Aushdhalaya Ltd, a key player in the Pharmaceuticals & Biotechnology sector, is currently experiencing severe selling pressure with no buyers in the queue, signalling distress selling and a notable shift in market sentiment. The stock has recorded consecutive declines over the past four days, reflecting a challenging phase for investors amid a broader market context.

Desh Rakshak Aushdhalaya Ltd has attracted remarkable buying interest, with the stock hitting an upper circuit and registering only buy orders in the queue. This unusual market activity signals a potential multi-day circuit scenario, reflecting strong demand despite recent price volatility.

Desh Rakshak Aushdhalaya Ltd has encountered significant selling pressure, registering a sharp decline over the past week with no buyers visible in the order book. The stock’s performance contrasts starkly with broader market trends, signalling distress selling and heightened investor caution.

Desh Rakshak Aushdhalaya Ltd experienced a pronounced decline in trading activity today, marked by exclusive selling interest and a sharp drop in its share price. The stock opened sharply lower and remained at its intraday low throughout the session, signalling distress selling and a lack of buyer support in the Pharmaceuticals & Biotechnology sector.

Desh Rakshak Aushdhalaya Ltd experienced a pronounced downturn on 21 Nov 2025, marked by exclusive selling activity and a significant drop in its share price. The stock’s performance today starkly contrasts with broader market trends, signalling distress selling and heightened investor caution within the Pharmaceuticals & Biotechnology sector.

Desh Rakshak Aushdhalaya Ltd has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. This surge reflects a strong demand in the Pharmaceuticals & Biotechnology sector, with the stock showing a remarkable streak of consecutive gains and a potential for a multi-day circuit scenario.

Desh Rakshak Aushdhalaya Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has witnessed extraordinary buying interest today, hitting the upper circuit with only buy orders in the queue. This rare market phenomenon signals robust demand and a potential multi-day circuit scenario, underscoring the stock’s strong momentum despite mixed medium-term performance.

Desh Rakshak Aushdhalaya Ltd., the century-old Ayurvedic and herbal products manufacturer, reported a challenging second quarter for FY2026, with net profit declining to ₹0.08 crores in Q2 FY26 from ₹0.10 crores in Q1 FY26, marking a sequential decline of 20.00%. The company's stock, trading at ₹41.11 with a market capitalisation of ₹23.00 crores, has experienced significant volatility, down 51.23% over the past three months despite posting a remarkable 186.88% gain over the past year.

Desh Rakshak Aushdhalaya, a microcap in the Pharmaceuticals & Biotechnology sector, reported net sales of Rs 6.64 crore for the nine-month period, reflecting a 39.50% growth. However, challenges include a low debtors turnover ratio and a dip in earnings per share, despite impressive long-term market performance.

Desh Rakshak Aushdhalaya Ltd, a microcap in the Pharmaceuticals & Biotechnology sector, is experiencing notable buying activity, with a recent surge in stock performance. Despite a challenging month, its year-to-date gains significantly exceed broader market trends, reflecting strong investor interest and sector dynamics.

Desh Rakshak Aushdhalaya Ltd, a microcap in the Pharmaceuticals & Biotechnology sector, is experiencing heightened buying activity, significantly outperforming the broader market. The stock has shown impressive momentum over the past week and remains resilient despite recent declines, reflecting strong buyer interest and positive market sentiment.

Desh Rakshak Aushdhalaya Ltd, a microcap in the Pharmaceuticals & Biotechnology sector, is experiencing notable buying activity, with a recent increase in stock price. Over the past week, it has shown a significant rise, contrasting with the broader market's performance. Despite a challenging month, its year-to-date gains remain strong.

Desh Rakshak Aushdhalaya, a microcap in the Pharmaceuticals & Biotechnology sector, has seen a recent score adjustment reflecting a shift in technical trends. The company reported a 59.38% growth in net sales for the quarter ending June 2025, despite a decrease in promoter holding and weak long-term fundamentals.